x_label	specimen_descriptor_fill	box_sample_count	Gene_Ensembl_ID	Gene_symbol	PMTL	Dataset	Disease	GTEx_tissue_subgroup	EFO	MONDO	GTEx_tissue_subgroup_UBERON	TPM_mean	TPM_sd	TPM_min	TPM_25th_percentile	TPM_median	TPM_75th_percentile	TPM_max
Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 318)	Pediatric Primary Tumors	304	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Neuroblastoma		EFO_0000621	MONDO_0005072		51.98	42.32	0.81	25.48	39.79	63.6	323.67
Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 318)	Pediatric Relapse Tumors	14	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Neuroblastoma		EFO_0000621	MONDO_0005072		44.12	43.03	0.3	14.66	35.8	51.05	141.13
Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)	Pediatric Primary Tumors	129	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Neuroblastoma		EFO_0000621	MONDO_0005072		80.85	50.05	1.74	45.86	69.8	109.02	323.67
Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)	Pediatric Relapse Tumors	8	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	TARGET	Neuroblastoma		EFO_0000621	MONDO_0005072		65.84	44.94	13.26	38.32	48.88	88.86	141.13
Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 165)	TCGA Primary Tumors	152	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Glioblastoma Multiforme		EFO_0000519	MONDO_0018177		20.93	26.04	0.75	5.63	11.36	25.61	171.81
Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 165)	TCGA Relapse Tumors	13	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Glioblastoma Multiforme		EFO_0000519	MONDO_0018177		13.75	19.3	1.2	2.4	4.01	17.67	69.9
Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 521)	TCGA Primary Tumors	507	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Low-grade glioma		MONDO_0021637	MONDO_0021637		19.05	15.62	0.97	9.16	15.43	24.85	123.38
Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 521)	TCGA Relapse Tumors	14	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Low-grade glioma		MONDO_0021637	MONDO_0021637		26.63	16.71	4.4	13.83	27.83	33.23	58.78
Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 378)	TCGA Primary Tumors	373	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Ovarian Serous Cystadenocarcinoma		EFO_1000043	MONDO_0006046		3.07	4.6	0.11	0.8	1.6	3.31	44.87
Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 378)	TCGA Relapse Tumors	5	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Ovarian Serous Cystadenocarcinoma		EFO_1000043	MONDO_0006046		2.07	2.47	0.08	0.37	1.25	2.47	6.16
Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 261)	TCGA Primary Tumors	258	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Sarcoma		EFO_0000691	MONDO_0005089		4.86	6.28	0.15	1.35	2.63	5.95	51.12
Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 261)	TCGA Relapse Tumors	3	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 3.1)	TCGA	Sarcoma		EFO_0000691	MONDO_0005089		1.74	1.13	1.02	1.08	1.15	2.09	3.04
